News

Filter

Current filters:

None

176 to 185 of 98147 results

Hikma posts revenue growth of 9% and basic EPS up 30% for 2014

Hikma posts revenue growth of 9% and basic EPS up 30% for 2014

11-03-2015

Jordon-based drugmaker Hikma Pharmaceuticals today reported its preliminary results for the year ended…

FinancialHikma PharmaceuticalsPharmaceutical

India’s patent office revokes Boehringer’s Spiriva patent

India’s patent office revokes Boehringer’s Spiriva patent

11-03-2015

In a ‘landmark’ case, India's Patent Office has revoked a patent on family-owned German pharma major…

Boehringer IngelheimCiplaGenericsIndiaLegalRespiratory and PulmonarySpiriva

Eisai's Halaven to stay on UK Cancer Drugs Fund list pending reconsideration

Eisai's Halaven to stay on UK Cancer Drugs Fund list pending reconsideration

11-03-2015

Japanese drug major Eisai has announced that its drug Halaven (eribulin) will remain on the UK's National…

EisaiHalavenOncologyPharmaceuticalRegulationUK

Pernix to acquire Zohydro ER franchise from Zogenix

11-03-2015

US CNS focused drugmaker Zogenix has entered into a definitive agreement to sell its Zohydro ER (hydrocodone…

Mergers & AcquisitionsNeurologicalPernix TherapeuticsPharmaceuticalZogenixZohydro

Second $50M milestone for Ophthotech under Fovista deal with Novartis

11-03-2015

US biotech firm Ophthotech says it has achieved a second $50 million enrollment milestone from Swiss…

BiotechnologyFinancialFovistaNovartisOphthalmicsOphthotechResearch

Ocular Therapeutix reports positive top-line data from Phase III OTX-DP trial

Ocular Therapeutix reports positive top-line data from Phase III OTX-DP trial

11-03-2015

Biopharma company Ocular Therapeutix has announced positive top-line data from the first of two Phase…

Ocular TherapeutixOphthalmicsPharmaceuticalResearchUSA

AstraZeneca undertakes two-year collaboration with Singaporean organizations for heart failure

AstraZeneca undertakes two-year collaboration with Singaporean organizations for heart failure

11-03-2015

Anglo-Swedish drug major AstraZeneca is to undertake a two-year collaboration with leading organizations…

AstraZenecaCardio-vascularPharmaceuticalResearchSingapore

NICE says ‘yes’ to new blood cancer drug from Roche

NICE says ‘yes’ to new blood cancer drug from Roche

11-03-2015

Patients in England and Wales with chronic lymphocytic leukemia (CLL) could soon benefit from Gazyvaro…

BiotechnologyGazyvaroOncologyPricingRegulationRocheUK

176 to 185 of 98147 results

Back to top